Novel Treatment for Brain Injury
Neurorepair Inc., in cooperation with researchers at the University of California, Irvine, School of Medicine, has developed what is likely the world's most advanced technology for repair of neurological damage, an endeavor heretofore generally thought hopeless. Neurorepair has a highly effective, noninvasive, procedure that stimulates a massive proliferation, migration and differentiation of new neural cells that can replace those lost to stroke, injury or disease. Neurorepair is the sole owner of this intellectual property and has several pending Patent Applications. The company has no outside shareholders or investors, and no debt. It's research has been privately funded by the founder.
The only current treatment for certain patients who have experienced a stroke is tissue plasminogen activator (tPA), a clot-dissolving agent with a therapeutic window of only a few hours. It is used to treat fewer than 5% of patients. Stroke is the leading cause of long-term disability in the United States, where there are 700,000 strokes each year and more than 4.7 million stroke survivors.
Hot News
News Neurorepair has been named by Mark Anderson as a “Firestarter company” for this year’s Future in Review [FiRe] Conference.
"We believe that these FiReStarter businesses, which are integrated into the FiRe program, are on the cusp of making great strides in improving our world. They are businesses we believe you should know about." - Mark Anderson
Hosted by Mark Anderson, founder and publisher of the Strategic News Service™, the Future in Review [FiRe] Conference exposes world experts and participants to new ideas in a manner that produces an accurate portrait of the future in technology, including the global economy, cloud computing, biology and medical diagnostics, policy, netbooks, space travel, sustainability, and other fields that contribute to technology outcomes.
